Epidemiologic and viral factors associated with cervical neoplasia in HPV‐16‐positive women
Open Access
- 1 February 2005
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 115 (1) , 114-120
- https://doi.org/10.1002/ijc.20894
Abstract
While infection with high-risk HPV is the most important risk factor for cervical cancer, HPV alone is insufficient. Our purpose was to identify viral and epidemiologic factors associated with cervical disease in HPV-16 DNA-positive women referred to colposcopy. We used a standardized interview to collect epidemiologic data from consenting women. Total nucleic acids from exfoliated cervical cells were used for all viral assays (HPV detection and typing using L1 consensus PCR with line probe hybridization, variant classification by sequencing, viral load and transcript copy determination by quantitative PCR and transcript pattern by nested RT-PCR). Cervical disease was based on colposcopic biopsy. Logistic regression was used to calculate ORs with 95% CIs. There were 115 HPV-16 positive women among 839 enrollees. By univariate analyses, age >25 years (OR = 3.05, 95% CI 1.20–7.76), smoking (OR = 3.0, 95% CI 1.19–7.56), high viral load (OR = 5.27, 95% CI 2.05–13.60), detection of both E6 and E6*I transcripts (OR = 10.0, 95% CI 2.1–47.58) and high transcript copies (OR = 5.56, 95% CI 2.05–13.60) were significant risk factors for CIN III with reference to No CIN/CIN I. Less than a third of the women (31.5%) had prototype HPV-16 detected, and variants showed no association with disease, viral load or transcription. Viral DNA and transcript copies were highly correlated, and the ratio of transcript copies to DNA copies was not changed with disease status. While viral load, transcript copies and transcript pattern were statistically associated with CIN III, none of these measures effectively discriminated between HPV-16 women with disease requiring treatment and those who could be followed. Cellular proliferation and differentiation pathways affected by HPV should be investigated as biomarkers for cervical cancer screening.Keywords
This publication has 30 references indexed in Scilit:
- Persistence and load of high‐risk HPV are predictors for development of high‐grade cervical lesions: A longitudinal French cohort studyInternational Journal of Cancer, 2003
- Viral load as a predictor of the risk of cervical intraepithelial neoplasiaInternational Journal of Cancer, 2002
- Human Papillomavirus Type 16 Intratypic Variant Infection and Risk for Cervical Neoplasia in Southern ChinaThe Journal of Infectious Diseases, 2002
- Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real‐time polymerase chain reaction analysisCancer, 2002
- Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearanceInternational Journal of Cancer, 2002
- Use of Real-Time Quantitative PCR to Validate the Results of cDNA Array and Differential Display PCR TechnologiesMethods, 2001
- Enhancer‐promoter Activity of Human Papillomavirus Type 16 Long Control Regions Isolated from Cell Lines SiHa and CaSki and Cervical Cancer BiopsiesJapanese Journal of Cancer Research, 2000
- Human Papillomavirus Types 16 E6 and E7 Contribute Differently to CarcinogenesisVirology, 2000
- Detection of Human Papillomavirus Type 16 E6/E7 Oncogene Transcripts in Dysplastic and Nondysplastic Cervical Scrapes by Nested RT-PCRGynecologic Oncology, 1998
- Natural History of Cervicovaginal Papillomavirus Infection in Young WomenNew England Journal of Medicine, 1998